Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?

Front Endocrinol (Lausanne) · 2022 · PMC9585180 · PMID 36277718

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

Lipid-lowering medication was associated with an increased risk of progression to diabetes in univariable analysis (RRR = 1.89; 95% CI, 1.08-3.30) but decreased the regression to diabetes by about 2-fold with a borderline significance (RRR = 0.55; 95% CI, 0.28-1.08).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.